Chemicals and Drugs

Hemoglobin E

An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Aspects Covered

30 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

Indexing Annotation

/urine: coordinate with HEMOGLOBINURIA

MeSH Record

History Note

91(77); was see under HEMOGLOBINS, ABNORMAL 1977-90

MeSH Record

Previous Indexing

  • Hemoglobins, Abnormal (1966-1976)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Hemoglobin E. Medical Subject Headings (MeSH). 2026. Unique ID D006446. http://id.nlm.nih.gov/mesh/2026/D006446
  2. Hemoglobin E. In: Wikipedia. https://en.wikipedia.org/wiki/Hemoglobin_E
  3. Hemoglobin E. In: Wikidata. https://www.wikidata.org/wiki/Q17022356